001     179064
005     20240229145531.0
024 7 _ |a 10.3390/ijms23031295
|2 doi
024 7 _ |a pmid:35163215
|2 pmid
024 7 _ |a pmc:PMC8836109
|2 pmc
024 7 _ |a 1422-0067
|2 ISSN
024 7 _ |a 1661-6596
|2 ISSN
037 _ _ |a DKFZ-2022-00442
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Miao, Beiping
|0 P:(DE-He78)b5b786a7a28d851956ba90aa9451887a
|b 0
|e First author
|u dkfz
245 _ _ |a Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer.
260 _ _ |a Basel
|c 2022
|b Molecular Diversity Preservation International
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1646821948_1989
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:B062#LA:B062#
520 _ _ |a Colorectal cancer (CRC) is the third most frequently diagnosed malignancy worldwide. Only 5% of all CRC cases are due to germline mutations in known predisposition genes, and the remaining genetic burden still has to be discovered. In this study, we performed whole-exome sequencing on six members of a Polish family diagnosed with CRC and identified a novel germline variant in the protein tyrosine kinase 7 (inactive) gene (PTK7, ENST00000230419, V354M). Targeted screening of the variant in 1705 familial CRC cases and 1674 healthy elderly individuals identified the variant in an additional familial CRC case. Introduction of this variant in HT-29 cells resulted in increased cell proliferation, migration, and invasion; it also caused down-regulation of CREB, p21 and p53 mRNA and protein levels, and increased AKT phosphorylation. These changes indicated inhibition of apoptosis pathways and activation of AKT signaling. Our study confirmed the oncogenic function of PTK7 and supported its role in genetic predisposition of familial CRC.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a AKT signaling pathway
|2 Other
650 _ 7 |a PTK7
|2 Other
650 _ 7 |a colorectal cancer
|2 Other
650 _ 7 |a familial cancer variant prioritization pipeline
|2 Other
650 _ 7 |a familial cancers
|2 Other
650 _ 7 |a germline variant
|2 Other
650 _ 7 |a CDKN1A protein, human
|2 NLM Chemicals
650 _ 7 |a CREB1 protein, human
|2 NLM Chemicals
650 _ 7 |a Cell Adhesion Molecules
|2 NLM Chemicals
650 _ 7 |a Cyclic AMP Response Element-Binding Protein
|2 NLM Chemicals
650 _ 7 |a Cyclin-Dependent Kinase Inhibitor p21
|2 NLM Chemicals
650 _ 7 |a Tumor Suppressor Protein p53
|2 NLM Chemicals
650 _ 7 |a PTK7 protein, human
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Receptor Protein-Tyrosine Kinases
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-akt
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Cell Adhesion Molecules: genetics
|2 MeSH
650 _ 2 |a Cell Adhesion Molecules: metabolism
|2 MeSH
650 _ 2 |a Cell Movement: genetics
|2 MeSH
650 _ 2 |a Cell Proliferation: genetics
|2 MeSH
650 _ 2 |a Colorectal Neoplasms: genetics
|2 MeSH
650 _ 2 |a Colorectal Neoplasms: pathology
|2 MeSH
650 _ 2 |a Cyclic AMP Response Element-Binding Protein: genetics
|2 MeSH
650 _ 2 |a Cyclin-Dependent Kinase Inhibitor p21: genetics
|2 MeSH
650 _ 2 |a Family
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease
|2 MeSH
650 _ 2 |a Germ-Line Mutation: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Neoplasm Invasiveness: genetics
|2 MeSH
650 _ 2 |a Oncogenes
|2 MeSH
650 _ 2 |a Pedigree
|2 MeSH
650 _ 2 |a Proto-Oncogene Proteins c-akt: genetics
|2 MeSH
650 _ 2 |a Receptor Protein-Tyrosine Kinases: genetics
|2 MeSH
650 _ 2 |a Receptor Protein-Tyrosine Kinases: metabolism
|2 MeSH
650 _ 2 |a Tumor Suppressor Protein p53: genetics
|2 MeSH
650 _ 2 |a Whole Exome Sequencing: methods
|2 MeSH
700 1 _ |a Skopelitou, Diamanto
|0 P:(DE-He78)cea283034a4f6c64994f85d4444e7494
|b 1
700 1 _ |a Srivastava, Aayushi
|0 P:(DE-He78)43b43c5f20ed70299251a446ad8ec973
|b 2
700 1 _ |a Giangiobbe, Sara
|0 P:(DE-He78)f18e077aae13edd9d0d8b911cfcd8e0f
|b 3
700 1 _ |a Dymerska, Dagmara
|b 4
700 1 _ |a Paramasivam, Nagarajan
|b 5
700 1 _ |a Kumar, Abhishek
|0 P:(DE-He78)da09d83faa85c143d15611698f7b1eac
|b 6
700 1 _ |a Kuświk, Magdalena
|0 0000-0001-9070-747X
|b 7
700 1 _ |a Kluźniak, Wojciech
|b 8
700 1 _ |a Paszkowska-Szczur, Katarzyna
|b 9
700 1 _ |a Schlesner, Matthias
|0 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37
|b 10
|u dkfz
700 1 _ |a Lubinski, Jan
|0 0000-0003-2931-3003
|b 11
700 1 _ |a Hemminki, Kari
|0 P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865
|b 12
|u dkfz
700 1 _ |a Försti, Asta
|0 P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696
|b 13
|u dkfz
700 1 _ |a Bandapalli, Obul Reddy
|0 P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc
|b 14
|e Last author
773 _ _ |a 10.3390/ijms23031295
|g Vol. 23, no. 3, p. 1295 -
|0 PERI:(DE-600)2019364-6
|n 3
|p 1295
|t International journal of molecular sciences
|v 23
|y 2022
|x 1422-0067
909 C O |o oai:inrepo02.dkfz.de:179064
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b5b786a7a28d851956ba90aa9451887a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)cea283034a4f6c64994f85d4444e7494
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)43b43c5f20ed70299251a446ad8ec973
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)f18e077aae13edd9d0d8b911cfcd8e0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)da09d83faa85c143d15611698f7b1eac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-05-04
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-05-04
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-09-04T08:27:04Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-09-04T08:27:04Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-09-04T08:27:04Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J MOL SCI : 2021
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2022-11-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J MOL SCI : 2021
|d 2022-11-25
920 2 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)C050-20160331
|k C050
|l Molekular-Genetische Epidemiologie
|x 2
920 1 _ |0 I:(DE-He78)W610-20160331
|k W610
|l W610 Omics IT and Data Management
|x 3
920 0 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C050-20160331
980 _ _ |a I:(DE-He78)W610-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21